Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438139 · ClinicalTrials.gov registry record · Phase 1
Ph1 Marinol Interaction Study - Part 1 - 1
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00438139 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 6 participants.
The verdict
NCT00438139, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant interactions before conducting outpatient studies.
Interventions
- DRUG Dronabinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-03 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438139
The ClinicalTrials.gov registry entry for NCT00438139 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dronabinol is the first listed.
NCT00438139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438139 about?
NCT00438139 is a clinical study titled "Ph1 Marinol Interaction Study - Part 1 - 1". The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determi...
What is the current status of trial NCT00438139?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00438139?
The interventions under investigation include: Dronabinol (DRUG).
Who is sponsoring clinical trial NCT00438139?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.